It took several attempts and much debate, but on Friday, the Centers for Disease Control and Prevention's (CDC’s) newly ...

Interestingly, despite the autumn’s upward trend, November’s haul is the first in 2025 that doesn’t outweigh the ...

Avalere Health has hired Sarah Hall as president of U.S. marketing, tapping the direct-to-consumer expert to lead its team ...

With FDA approval to treat marginal zone lymphoma (MZL), Bristol Myers Squibb’s Breyanzi has become the first CAR-T therapy ...

Uncertainty reigned early this year with the inauguration of President Donald Trump and his threats to impose tariffs and ...

Halozyme is seeing some progress in its global effort to defend intellectual property against alleged infringement by Merck & ...

The FDA is investigating a safety signal from Takeda’s rare disease med Adzynma. Otsuka won a first-in-class FDA approval to ...

The Centers for Disease Control and Prevention's (CDC’s) newly reworked Advisory Committee on Immunization Practices (ACIP) ...

After many months of uncertainty related to the Biosecure Act and associated security efforts in Washington, D.C., Chinese ...

Drastic overhauls of U.S. vaccine regulations proposed by top FDA official Vinay Prasad, M.D., have drawn harsh pushback from ...

A trio of drugmakers are treading the boards to raise awareness of global antimicrobial resistance (AMR). | A trio of ...

Cosmo Pharmaceuticals has revealed topline results from two phase 3 trials which indicate that its topical cream clascoterone ...